To extend our findings linking Tspan6 and EGFR-dependent signaling in colorectal cancer, we investigated whether the expression of Tspan6 can predict a response to the EGFR-targeting therapies in vivo. This evidence concerns the gene TSPAN6 and colorectal cancer.